Evidence map›Paper›PMID 36737749›Full record

ReviewBMC neurology2023

Small vessel childhood primary angiitis of the central nervous system with positive anti-glial fibrillary acidic protein antibodies: a case report and review of literature.

E Datyner, V Adeseye, K Porter, I Dryden, A Sarma, N Vu, A E Patrick, P Paueksakon

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in BMC neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

E DatynerDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
V AdeseyeDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
K PorterVanderbilt University, Nashville, TN, USA.
I DrydenDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 1161 21St Avenue South, Nashville, TN, MCN C2318B37232-2561, USA.
A SarmaDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
N VuDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
A E PatrickDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
P PaueksakonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, 1161 21St Avenue South, Nashville, TN, MCN C2318B37232-2561, USA. paisit.paueksakon@vumc.org.
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood DiseaseK12HD087023 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael R. DeBaun, Juan C Salazar · 2016 to 2026
$4.1M
Mechanisms of T Cell IFNy and IL-17 Production in Juvenile Idiopathic ArthritisK08AR081405 · NIAMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Anna Elizabeth Patrick · 2022 to 2026
$819k
NIAMS NIH HHS K08 AR081405NICHD NIH HHS K12 HD087023
6 · The paper itself

Abstract

backgroundSmall vessel childhood primary angiitis of the central nervous system (SV-cPACNS) is a rare disease characterized by inflammation within small vessels such as arterioles or capillaries. CASE PRESENTATION: We report a case of SV-cPACNS in an 8-year-old boy confirmed by brain biopsy. This patient was also incidentally found to have anti-glial fibrillary acidic protein (GFAP) antibodies in the cerebrospinal fluid (CSF) but had no evidence of antibody-mediated disease on brain biopsy. A literature review highlighted the rarity of SV-cPACNS and found no prior reports of CSF GFAP-associated SV-cPACNS in the pediatric age group.

conclusionWe present the first case of biopsy proven SV-cPACNS vasculitis associated with an incidental finding of CSF GFAP antibodies. The GFAP antibodies are likely a clinically insignificant bystander in this case and possibly in other diseases with CNS inflammation. Further research is needed to determine the clinical significance of newer CSF autoantibodies such as anti-GFAP before they are used for medical decision-making in pediatrics.

Indexed as

Vasculitis, Central Nervous SystemAutoantibodiesChildHumansInflammationMaleanti-GFAP autoantibodiesAutoantibodiesAnti-glial fibrillary acidic protein antibodiesBrain biopsySmall vessel childhood primary angiitis of the central nervous system

Identifiers

PMID36737749
PMCPMC9895965
OpenAlexW4319161779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.